group_id,Component_25,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00643,1.4084073751963335,FUN_001887-T1,Peve_00030489,Pocillopora_meandrina_HIv1___RNAseq.g29129.t1,three_way,64.38266666666667,FUN_001887-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),40.6,286.0,1.8000000000000002e-44,181.8,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_03933,1.3674949803204726,FUN_016049-T1,Peve_00011814,Pocillopora_meandrina_HIv1___RNAseq.g21636.t1,three_way,52.112,,,,,,,,,,,,,,,,,
OG_05071,1.3474347904401784,FUN_023293-T1,Peve_00003652,Pocillopora_meandrina_HIv1___RNAseq.g23035.t1,three_way,68.382,,,,,,,,,,,,,,,,,
OG_00531,1.2891242797400706,FUN_001545-T1,Peve_00033291,Pocillopora_meandrina_HIv1___RNAseq.g15386.t1,three_way,49.809666666666665,,,,,,,,,,,,,,,,,
OG_01324,1.124165406042115,FUN_005194-T1,Peve_00001277,Pocillopora_meandrina_HIv1___RNAseq.g15136.t1,three_way,66.81283333333333,,,,,,,,,,,,,,,,,
OG_00499,1.07891368240971,FUN_001472-T1,Peve_00026259,Pocillopora_meandrina_HIv1___RNAseq.g1911.t1,three_way,72.17666666666666,FUN_001472-T1,Q8VHT6,AS3MT_RAT,,Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase),Rattus norvegicus (Rat),46.2,366.0,6.1e-86,319.3,sp|Q8VHT6|AS3MT_RAT Arsenite methyltransferase OS=Rattus norvegicus OX=10116 GN=As3mt PE=1 SV=1,GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685,arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404],cytosol [GO:0005829],arsenite methyltransferase activity [GO:0030791]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_09775,1.0309802645862272,FUN_042071-T1,Peve_00038496,Pocillopora_meandrina_HIv1___RNAseq.g6232.t1,three_way,63.51566666666667,FUN_042071-T1,Q96MM6,,,,,35.6,643.0,1.3e-106,388.7,sp|Q96MM6|HS12B_HUMAN Heat shock 70 kDa protein 12B OS=Homo sapiens OX=9606 GN=HSPA12B PE=1 SV=2,,,,,,
OG_03932,1.018584824075904,FUN_016048-T1,Peve_00011790,Pocillopora_meandrina_HIv1___RNAseq.g26043.t1,three_way,52.87083333333334,,,,,,,,,,,,,,,,,
OG_03269,0.9079746610880388,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_09295,0.9019886195360844,FUN_040146-T1,Peve_00038108,Pocillopora_meandrina_HIv1___RNAseq.g8511.t1,three_way,40.80866666666667,,,,,,,,,,,,,,,,,
OG_09783,0.9002940232220271,FUN_042583-T1,Peve_00034294,Pocillopora_meandrina_HIv1___RNAseq.g16882.t1,three_way,83.662,FUN_042583-T1,P09132,SRP19_HUMAN,,Signal recognition particle 19 kDa protein (SRP19),Homo sapiens (Human),47.1,140.0,3.1000000000000002e-27,122.9,sp|P09132|SRP19_HUMAN Signal recognition particle 19 kDa protein OS=Homo sapiens OX=9606 GN=SRP19 PE=1 SV=3,GO:0003723; GO:0005730; GO:0005786; GO:0005829; GO:0006613; GO:0006617; GO:0008312; GO:0016604; GO:0048500,"cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]","cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]",7S RNA binding [GO:0008312]; RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0005829; GO:0043226; GO:0065003,RNA binding; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_00453,0.8826863146117121,FUN_001377-T1,Peve_00021886,Pocillopora_meandrina_HIv1___RNAseq.g2136.t1,three_way,56.78516666666667,,,,,,,,,,,,,,,,,
OG_05183,0.8751268571899838,FUN_023529-T1,Peve_00044316,Pocillopora_meandrina_HIv1___TS.g7657.t1,three_way,73.594,,,,,,,,,,,,,,,,,
OG_06218,0.8684003930494355,FUN_028160-T1,Peve_00000617,Pocillopora_meandrina_HIv1___RNAseq.g29828.t1,three_way,77.55183333333333,,,,,,,,,,,,,,,,,
OG_09826,0.8659956642714552,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_08229,0.8657546637831802,FUN_036101-T1,Peve_00032197,Pocillopora_meandrina_HIv1___RNAseq.g10817.t1,three_way,53.59666666666666,,,,,,,,,,,,,,,,,
OG_09021,0.8597496014628111,FUN_038610-T1,Peve_00002803,Pocillopora_meandrina_HIv1___RNAseq.g988.t1,three_way,58.11266666666667,FUN_038610-T1,Q60437,BAIP2_CRIGR,,BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),31.7,221.0,2.2e-23,111.7,sp|Q60437|BAIP2_CRIGR BAR/IMD domain-containing adapter protein 2 OS=Cricetulus griseus OX=10029 GN=BAIAP2 PE=1 SV=1,GO:0001726; GO:0005654; GO:0005829; GO:0005856; GO:0007009; GO:0008093; GO:0008360; GO:0016020; GO:0030175; GO:0030838; GO:0032956; GO:0051017; GO:0051764; GO:0070064,actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],cytoskeletal anchor activity [GO:0008093]; proline-rich region binding [GO:0070064],GO:0005654; GO:0005829; GO:0005856; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; cytosol; cytoskeleton; organelle; molecular adaptor activity; membrane organization
OG_04651,0.8560954047918301,FUN_022386-T3,Peve_00037603,Pocillopora_meandrina_HIv1___RNAseq.g9310.t1,three_way,63.92666666666666,FUN_022386-T3,B8V7S0,,,,,48.6,251.0,2.8e-62,241.5,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_09130,0.8520100334068016,FUN_039512-T1,Peve_00003617,Pocillopora_meandrina_HIv1___RNAseq.g27137.t1,three_way,55.90733333333333,,,,,,,,,,,,,,,,,
OG_07911,0.8367401394210081,FUN_035369-T1,Peve_00016219,Pocillopora_meandrina_HIv1___TS.g3559.t1,three_way,73.006,FUN_035369-T1,Q5ZIJ9,,,,,36.0,100.0,7e-11,70.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_04961,0.8091412367488996,FUN_023053-T1,Peve_00027088,Pocillopora_meandrina_HIv1___RNAseq.g13314.t1,three_way,61.67966666666666,,,,,,,,,,,,,,,,,
OG_05351,0.7887839572778312,FUN_024121-T1,Peve_00000177,Pocillopora_meandrina_HIv1___RNAseq.g19176.t1,three_way,46.95433333333333,,,,,,,,,,,,,,,,,
OG_01297,0.7828521483061373,FUN_005131-T1,Peve_00027431,Pocillopora_meandrina_HIv1___RNAseq.g22688.t1,three_way,57.669,FUN_005131-T1,P12256,,,,,31.2,321.0,7.1e-39,162.9,sp|P12256|PAC_LYSSH Penicillin V acylase OS=Lysinibacillus sphaericus OX=1421 PE=1 SV=1,,,,,,
OG_10099,0.7694462992044611,FUN_043435-T1,Peve_00028842,Pocillopora_meandrina_HIv1___RNAseq.g7834.t1,three_way,66.19233333333334,FUN_043435-T1,Q9WU63,,,,,37.7,151.0,4.9e-23,110.5,sp|Q9WU63|HEBP2_MOUSE Heme-binding protein 2 OS=Mus musculus OX=10090 GN=Hebp2 PE=1 SV=1,,,,,,
OG_03070,0.758463268307169,FUN_012340-T1,Peve_00042542,Pocillopora_meandrina_HIv1___RNAseq.g23343.t1,three_way,61.76633333333333,FUN_012340-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),30.7,205.0,2.5e-17,91.7,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_06215,0.7556096431536182,FUN_028156-T1,Peve_00027512,Pocillopora_meandrina_HIv1___RNAseq.g16461.t1,three_way,34.681666666666665,,,,,,,,,,,,,,,,,
OG_09674,0.7451359488340069,FUN_041896-T1,Peve_00026173,Pocillopora_meandrina_HIv1___RNAseq.6056_t,three_way,57.614666666666665,FUN_041896-T1,Q90WM5,,,,,36.3,292.0,2.0000000000000002e-29,131.7,sp|Q90WM5|DMRT3_TAKRU Doublesex- and mab-3-related transcription factor 3 OS=Takifugu rubripes OX=31033 GN=dmrt3 PE=2 SV=2,,,,,,
OG_01955,0.7358385033902992,FUN_008021-T1,Peve_00031303,Pocillopora_meandrina_HIv1___RNAseq.g30342.t1,three_way,69.569,,,,,,,,,,,,,,,,,
OG_07400,0.7323356541798955,FUN_033839-T1,Peve_00016490,Pocillopora_meandrina_HIv1___RNAseq.g26367.t1,three_way,53.79466666666666,,,,,,,,,,,,,,,,,
OG_02587,0.7312421297662985,FUN_010707-T1,Peve_00005096,Pocillopora_meandrina_HIv1___RNAseq.g8834.t1,three_way,53.306333333333335,FUN_010707-T1,A0A2B4RP11,,,,,26.2,378.0,3.4e-14,81.6,sp|A0A2B4RP11|CGLR1_STYPI Cyclic GMP-AMP synthase-like receptor 1 OS=Stylophora pistillata OX=50429 GN=cGLR1 PE=1 SV=1,,,,,,
OG_09091,0.72533431248297,FUN_038889-T1,Peve_00028699,Pocillopora_meandrina_HIv1___RNAseq.g28663.t1,three_way,51.704,,,,,,,,,,,,,,,,,
OG_08341,0.7198371795375917,FUN_036858-T1,Peve_00001065,Pocillopora_meandrina_HIv1___RNAseq.g27061.t1,three_way,76.1845,FUN_036858-T1,P22412,,,,,50.9,369.0,1.1e-104,381.7,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_09247,0.717646649774463,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02532,0.7157493295628398,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_06757,0.7120703309764324,FUN_031570-T1,Peve_00021507,Pocillopora_meandrina_HIv1___RNAseq.g5065.t1,three_way,57.521,FUN_031570-T1,D4A218,,,,,32.0,303.0,1.1e-26,122.5,sp|D4A218|DMRT3_RAT Doublesex and mab-3 related transcription factor 3 OS=Rattus norvegicus OX=10116 GN=Dmrt3 PE=3 SV=1,,,,,,
OG_00304,0.7117727429741929,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_00195,0.7047853311395417,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_02101,0.7028111033284556,FUN_008377-T1,Peve_00024686,Pocillopora_meandrina_HIv1___RNAseq.g18396.t1,three_way,53.3375,,,,,,,,,,,,,,,,,
OG_01486,0.6997869398786309,FUN_006162-T1,Peve_00024180,Pocillopora_meandrina_HIv1___RNAseq.g20422.t1,three_way,46.14,FUN_006162-T1,Q90827,,,,,30.2,129.0,2.5e-09,65.1,sp|Q90827|NEL_CHICK Protein NEL OS=Gallus gallus OX=9031 GN=NEL PE=2 SV=1,,,,,,
OG_06909,0.698432118508341,FUN_031967-T1,Peve_00013260,Pocillopora_meandrina_HIv1___RNAseq.g17806.t1,three_way,83.551,FUN_031967-T1,Q95M17,CHIA_BOVIN,,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04),Bos taurus (Bovine),46.4,390.0,4.3999999999999996e-91,336.7,sp|Q95M17|CHIA_BOVIN Acidic mammalian chitinase OS=Bos taurus OX=9913 GN=CHIA PE=1 SV=1,GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0008843; GO:0032722,apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005975; GO:0012501; GO:0016787; GO:1901135,immune system process; catalytic activity; extracellular region; extracellular space; carbohydrate metabolic process; programmed cell death; hydrolase activity; carbohydrate derivative metabolic process
OG_08226,0.6906375953292171,FUN_036097-T2,Peve_00032194,Pocillopora_meandrina_HIv1___RNAseq.g27437.t1,three_way,61.02516666666666,FUN_036097-T2,Q801E2,ANLN_XENLA,,Anillin,Xenopus laevis (African clawed frog),34.7,432.0,4.6e-56,221.5,sp|Q801E2|ANLN_XENLA Anillin OS=Xenopus laevis OX=8355 GN=anln PE=1 SV=1,GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005826; GO:0005938; GO:0031106; GO:0032059; GO:1904172,actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; septin ring organization [GO:0031106],actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; nucleus [GO:0005634],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0007010; GO:0008092; GO:0043226,cytokinesis; nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_03677,0.6899131693734657,FUN_014931-T1,Peve_00037145,Pocillopora_meandrina_HIv1___RNAseq.g21089.t1,three_way,68.721,FUN_014931-T1,Q4FAT7,,,,,40.9,580.0,7.9e-123,442.6,sp|Q4FAT7|BGLR_PIG Beta-glucuronidase OS=Sus scrofa OX=9823 GN=GUSB PE=3 SV=1,,,,,,
OG_03122,0.6882490843938778,FUN_012476-T1,Peve_00004005,Pocillopora_meandrina_HIv1___RNAseq.g23990.t1,three_way,74.48633333333333,FUN_012476-T1,O15247,CLIC2_HUMAN,,Chloride intracellular channel protein 2 (Glutaredoxin-like oxidoreductase CLIC2) (EC 1.8.-.-) (Glutaredoxin-like peroxidase CLIC2) (EC 1.11.1.-) (XAP121),Homo sapiens (Human),31.7,230.0,1.5e-23,111.3,sp|O15247|CLIC2_HUMAN Chloride intracellular channel protein 2 OS=Homo sapiens OX=9606 GN=CLIC2 PE=1 SV=3,GO:0004602; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707,chloride transport [GO:0006821]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602],GO:0003824; GO:0005215; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016209; GO:0016491; GO:0043226,catalytic activity; transporter activity; nucleus; nucleoplasm; cytosol; plasma membrane; antioxidant activity; oxidoreductase activity; organelle
OG_08967,0.6764256687311213,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_06922,0.6754412120878176,FUN_032012-T1,Peve_00028791,Pocillopora_meandrina_HIv1___RNAseq.g30267.t1,three_way,74.29599999999999,FUN_032012-T1,Q20191,,,,,44.3,228.0,1.5e-45,185.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_07692,0.6723064686410091,FUN_034819-T1,Peve_00041509,Pocillopora_meandrina_HIv1___RNAseq.g27216.t1,three_way,74.395,FUN_034819-T1,Q9R088,,,,,47.5,204.0,1.1e-52,208.4,"sp|Q9R088|KITM_MOUSE Thymidine kinase 2, mitochondrial OS=Mus musculus OX=10090 GN=Tk2 PE=1 SV=2",,,,,,
OG_05226,0.6666872922595972,FUN_023639-T1,Peve_00027828,Pocillopora_meandrina_HIv1___RNAseq.g17814.t1c,three_way,45.796,,,,,,,,,,,,,,,,,
OG_04890,0.6666030617277623,FUN_022933-T1,Peve_00016029,Pocillopora_meandrina_HIv1___RNAseq.g3734.t1,three_way,55.45366666666667,,,,,,,,,,,,,,,,,
OG_00455,0.6572098385633759,FUN_001384-T1,Peve_00019346,Pocillopora_meandrina_HIv1___TS.g4636.t2,three_way,67.6845,,,,,,,,,,,,,,,,,
OG_02226,0.6547794653671098,FUN_008631-T1,Peve_00012388,Pocillopora_meandrina_HIv1___RNAseq.g14912.t1,three_way,62.56166666666666,,,,,,,,,,,,,,,,,
OG_00314,0.6543236933759542,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_04538,0.6525294688975216,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_06678,0.6475183457580487,FUN_031081-T1,Peve_00031208,Pocillopora_meandrina_HIv1___RNAseq.g25502.t1,three_way,48.558,,,,,,,,,,,,,,,,,
OG_07265,0.6464862969868068,FUN_033056-T1,Peve_00024296,Pocillopora_meandrina_HIv1___RNAseq.g25129.t1,three_way,51.20366666666667,FUN_033056-T1,Q9UGM3,,,,,54.1,218.0,8e-62,239.6,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_04693,0.6461470442366197,FUN_022485-T1,Peve_00002925,Pocillopora_meandrina_HIv1___RNAseq.g4293.t1,three_way,88.12733333333333,,,,,,,,,,,,,,,,,
OG_00957,0.6437581106003856,FUN_004321-T1,Peve_00016506,Pocillopora_meandrina_HIv1___RNAseq.g11786.t1,three_way,75.91266666666667,FUN_004321-T1,P54357,,,,,42.0,143.0,3.7e-23,109.4,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_04250,0.643711042101423,FUN_017780-T1,Peve_00029909,Pocillopora_meandrina_HIv1___RNAseq.g9514.t1,three_way,48.56066666666667,,,,,,,,,,,,,,,,,
OG_03429,0.637031669668228,FUN_014485-T1,Peve_00037303,Pocillopora_meandrina_HIv1___RNAseq.g22811.t1,three_way,75.97416666666666,FUN_014485-T1,O35887,,,,,29.0,155.0,5.5e-09,63.5,sp|O35887|CALU_MOUSE Calumenin OS=Mus musculus OX=10090 GN=Calu PE=1 SV=1,,,,,,
OG_02718,0.636121534109897,FUN_011001-T1,Peve_00013415,Pocillopora_meandrina_HIv1___RNAseq.g22019.t1,three_way,62.246,FUN_011001-T1,A8WFU8,KIF22_DANRE,,Kinesin-like protein KIF22,Danio rerio (Zebrafish) (Brachydanio rerio),41.6,632.0,3.4e-120,433.7,sp|A8WFU8|KIF22_DANRE Kinesin-like protein KIF22 OS=Danio rerio OX=7955 GN=kif22 PE=2 SV=1,GO:0001756; GO:0001966; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007409; GO:0007420; GO:0008017; GO:0016887; GO:0021952; GO:0048592,axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; eye morphogenesis [GO:0048592]; microtubule-based movement [GO:0007018]; somitogenesis [GO:0001756]; thigmotaxis [GO:0001966],cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003677; GO:0003774; GO:0003824; GO:0005634; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0140657,DNA binding; cytoskeletal motor activity; catalytic activity; nucleus; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; anatomical structure development; ATP-dependent activity
OG_02537,0.6361063597238035,FUN_010620-T1,Peve_00031460,Pocillopora_meandrina_HIv1___TS.g26115.t1,three_way,50.77283333333333,FUN_010620-T1,O14514,AGRB1_HUMAN,,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],Homo sapiens (Human),29.6,659.0,1.9999999999999999e-63,246.9,sp|O14514|AGRB1_HUMAN Adhesion G protein-coupled receptor B1 OS=Homo sapiens OX=9606 GN=ADGRB1 PE=1 SV=2,GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016020; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]",cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786],GO:0002376; GO:0005615; GO:0005886; GO:0007155; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0060089; GO:0061024; GO:0098542,immune system process; extracellular space; plasma membrane; cell adhesion; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; molecular transducer activity; membrane organization; defense response to other organism
OG_04999,0.6324766252011681,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_07835,0.6294563327449361,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_02040,0.6282845056261167,FUN_008245-T1,Peve_00031789,Pocillopora_meandrina_HIv1___RNAseq.g17949.t1,three_way,80.146,,,,,,,,,,,,,,,,,
OG_01564,0.6262769883526472,FUN_006446-T2,Peve_00038423,Pocillopora_meandrina_HIv1___RNAseq.g20305.t1,three_way,34.80533333333334,,,,,,,,,,,,,,,,,
OG_03766,0.6238179589277866,FUN_015091-T1,Peve_00010707,Pocillopora_meandrina_HIv1___RNAseq.g21185.t1,three_way,59.72,,,,,,,,,,,,,,,,,
OG_08362,0.6234643990038004,FUN_036911-T1,Peve_00018411,Pocillopora_meandrina_HIv1___RNAseq.g10816.t1,three_way,73.75933333333333,FUN_036911-T1,P51614,,,,,32.5,292.0,1.1e-35,152.5,sp|P51614|CHIT3_VITVI Acidic endochitinase OS=Vitis vinifera OX=29760 GN=CHIT3 PE=2 SV=1,,,,,,
OG_06642,0.620908630155226,FUN_030643-T1,Peve_00006240,Pocillopora_meandrina_HIv1___RNAseq.g21086.t1,three_way,75.03066666666666,FUN_030643-T1,P52493,,,,,33.6,143.0,3.3e-19,96.3,sp|P52493|UBC2_NEUCR Ubiquitin-conjugating enzyme E2 2 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=mus-8 PE=3 SV=4,,,,,,
OG_00163,0.6197480098615951,FUN_000637-T1,Peve_00012867,Pocillopora_meandrina_HIv1___RNAseq.g16016.t1,three_way,83.68833333333333,FUN_000637-T1,O97125,,,,,74.2,613.0,9.1e-265,914.1,sp|O97125|HSP68_DROME Heat shock protein 68 OS=Drosophila melanogaster OX=7227 GN=Hsp68 PE=1 SV=1,,,,,,
OG_06382,0.6185655736489154,FUN_028994-T1,Peve_00034531,Pocillopora_meandrina_HIv1___RNAseq.g25641.t1,three_way,71.23533333333333,FUN_028994-T1,Q9UI42,CBPA4_HUMAN,,Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3),Homo sapiens (Human),39.8,402.0,5.9000000000000005e-87,322.8,sp|Q9UI42|CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens OX=9606 GN=CPA4 PE=1 SV=2,GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0042447; GO:0043171,hormone catabolic process [GO:0042447]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_05640,0.6183064830326368,FUN_025348-T1,Peve_00004327,Pocillopora_meandrina_HIv1___TS.g2360.t1a,three_way,40.693666666666665,,,,,,,,,,,,,,,,,
OG_05377,0.614193322061984,FUN_024194-T1,Peve_00018695,Pocillopora_meandrina_HIv1___RNAseq.g18881.t1,three_way,60.04266666666667,FUN_024194-T1,O75330,HMMR_HUMAN,,Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168),Homo sapiens (Human),45.3,148.0,1.2e-20,103.6,sp|O75330|HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens OX=9606 GN=HMMR PE=1 SV=2,GO:0005540; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005886; GO:0006898; GO:0009986; GO:0015630; GO:0016020; GO:0030214; GO:0038024,hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],cell surface [GO:0009986]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819],cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540],GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0016192; GO:0038024; GO:0043226; GO:1901135,microtubule organizing center; cytosol; cytoskeleton; plasma membrane; vesicle-mediated transport; cargo receptor activity; organelle; carbohydrate derivative metabolic process
OG_02486,0.6071082488214103,FUN_009818-T1,Peve_00042916,Pocillopora_meandrina_HIv1___RNAseq.g24548.t1,three_way,67.266,FUN_009818-T1,Q8MIR4,,,,,38.3,574.0,3.8e-94,347.1,sp|Q8MIR4|COASY_PIG Bifunctional coenzyme A synthase OS=Sus scrofa OX=9823 GN=COASY PE=1 SV=1,,,,,,
OG_06956,0.6067915458113159,FUN_032081-T1,Peve_00039910,Pocillopora_meandrina_HIv1___RNAseq.g5227.t1,three_way,79.99466666666666,FUN_032081-T1,Q5RE98,AOFB_PONAB,,Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.7,486.0,1.1000000000000001e-130,468.4,sp|Q5RE98|AOFB_PONAB Amine oxidase [flavin-containing] B OS=Pongo abelii OX=9601 GN=MAOB PE=2 SV=3,GO:0005739; GO:0005741; GO:0008131; GO:0050660; GO:0097621,,mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_06576,0.6035487188927225,FUN_029521-T2,Peve_00028580,Pocillopora_meandrina_HIv1___RNAseq.g17111.t1,three_way,61.62799999999999,FUN_029521-T2,P0DN10,,,,,63.5,52.0,2.7e-14,83.6,sp|P0DN10|VKT6_ANEVI U-actitoxin-Avd3i OS=Anemonia viridis OX=51769 PE=3 SV=1,,,,,,
OG_10047,0.6018303171875309,FUN_043320-T1,Peve_00018052,Pocillopora_meandrina_HIv1___TS.g20669.t1,three_way,62.268,FUN_043320-T1,Q5TYP4,,,,,30.4,859.0,4.3e-98,360.9,sp|Q5TYP4|FIRRM_DANRE FIGNL1-interacting regulator of recombination and mitosis OS=Danio rerio OX=7955 GN=firrm PE=2 SV=1,,,,,,
OG_01277,0.6016299593551763,FUN_005057-T1,Peve_00016734,Pocillopora_meandrina_HIv1___RNAseq.g8302.t1,three_way,72.20533333333333,FUN_005057-T1,Q8K596,NAC2_MOUSE,,Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2),Mus musculus (Mouse),37.3,499.0,1.4e-72,275.8,sp|Q8K596|NAC2_MOUSE Sodium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc8a2 PE=1 SV=1,GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015085; GO:0016323; GO:0035725; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070588; GO:0098815; GO:0099608; GO:0106056; GO:1902533; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of intracellular signal transduction [GO:1902533]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808],axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],calcium ion transmembrane transporter activity [GO:0015085]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; cell junction organization; organelle; nervous system process; transmembrane transport
OG_07000,0.5961699213209323,FUN_032151-T1,Peve_00003236,Pocillopora_meandrina_HIv1___RNAseq.g5328.t1,three_way,63.626333333333335,FUN_032151-T1,Q9NPA2,MMP25_HUMAN,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP),Homo sapiens (Human),36.2,384.0,6.7e-56,219.9,sp|Q9NPA2|MMP25_HUMAN Matrix metalloproteinase-25 OS=Homo sapiens OX=9606 GN=MMP25 PE=1 SV=1,GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0035579; GO:0060022; GO:0098552,collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; specific granule membrane [GO:0035579],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0006954; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular space; plasma membrane; inflammatory response; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_07144,0.5957062880356291,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_08098,0.5914070074796774,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_04737,0.590338181262681,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_00246,0.5899522662132027,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_09584,0.5877601721313803,FUN_041722-T1,Peve_00014616,Pocillopora_meandrina_HIv1___RNAseq.g15476.t1,three_way,61.13666666666667,,,,,,,,,,,,,,,,,
OG_06360,0.5876694167196103,FUN_028963-T1,Peve_00025110,Pocillopora_meandrina_HIv1___RNAseq.g25566.t1,three_way,55.882666666666665,,,,,,,,,,,,,,,,,
OG_04620,0.587399004656692,FUN_022322-T1,Peve_00021644,Pocillopora_meandrina_HIv1___RNAseq.g4643.t1,three_way,86.02233333333332,,,,,,,,,,,,,,,,,
OG_05637,0.5837060516005772,FUN_025338-T2,Peve_00000776,Pocillopora_meandrina_HIv1___RNAseq.g24106.t1,three_way,62.506,,,,,,,,,,,,,,,,,
OG_06708,0.5832250837307488,FUN_031289-T1,Peve_00026529,Pocillopora_meandrina_HIv1___RNAseq.g5169.t1,three_way,74.811,FUN_031289-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),58.3,599.0,8.2e-179,629.8,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_04819,0.5799146166195144,FUN_022805-T1,Peve_00018106,Pocillopora_meandrina_HIv1___RNAseq.g3479.t1,three_way,60.698,,,,,,,,,,,,,,,,,
OG_03910,0.5747729673712426,FUN_015986-T1,Peve_00024004,Pocillopora_meandrina_HIv1___RNAseq.g21398.t1,three_way,64.2585,,,,,,,,,,,,,,,,,
OG_00259,0.5736379106413162,FUN_001028-T1,Peve_00041059,Pocillopora_meandrina_HIv1___RNAseq.g29614.t1,three_way,51.323,,,,,,,,,,,,,,,,,
OG_06157,0.5729057236047583,FUN_028000-T1,Peve_00023138,Pocillopora_meandrina_HIv1___RNAseq.g14071.t1,three_way,85.642,FUN_028000-T1,Q80W32,DRC9_MOUSE,,Dynein regulatory complex protein 9 (IQ domain-containing protein G),Mus musculus (Mouse),40.1,357.0,2.6999999999999998e-62,240.7,sp|Q80W32|DRC9_MOUSE Dynein regulatory complex protein 9 OS=Mus musculus OX=10090 GN=Iqcg PE=1 SV=1,GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0015629; GO:0030544; GO:0031514; GO:0036126,sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544],GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0048856,cytosol; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; anatomical structure development
OG_01098,0.5723451157681103,FUN_004598-T1,Peve_00012407,Pocillopora_meandrina_HIv1___RNAseq.g6588.t1,three_way,65.93233333333333,,,,,,,,,,,,,,,,,
OG_05198,0.5697406397982826,FUN_023578-T1,Peve_00035142,Pocillopora_meandrina_HIv1___RNAseq.g3534.t2,three_way,64.644,FUN_023578-T1,O95786,RIGI_HUMAN,,Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),Homo sapiens (Human),35.5,716.0,2.1e-106,388.7,sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2,GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005829; GO:0005856; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; cytosol; cytoskeleton; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; molecular transducer activity; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06057,0.5694428905196242,FUN_026741-T2,Peve_00006716,Pocillopora_meandrina_HIv1___RNAseq.g9416.t1,three_way,57.72766666666666,FUN_026741-T2,Q8BKN6,,,,,53.6,261.0,1.3000000000000001e-71,271.6,sp|Q8BKN6|HS3SA_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 OS=Mus musculus OX=10090 GN=Hs3st3a1 PE=2 SV=1,,,,,,
OG_01177,0.5686531515063987,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_05031,0.5681366555217355,FUN_023205-T1,Peve_00010002,Pocillopora_meandrina_HIv1___RNAseq.g681.t2,three_way,61.8175,FUN_023205-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),41.3,150.0,3.5e-26,119.8,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_01704,0.5667329169541804,FUN_006949-T1,Peve_00001501,Pocillopora_meandrina_HIv1___RNAseq.g20122.t1,three_way,65.41066666666667,FUN_006949-T1,Q9D4H7,,,,,35.5,617.0,9e-100,365.9,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_00916,0.5652044538488772,FUN_004253-T1,Peve_00001928,Pocillopora_meandrina_HIv1___RNAseq.g11418.t1,three_way,75.71549999999999,FUN_004253-T1,Q9MA55,,,,,30.2,364.0,6e-33,143.7,sp|Q9MA55|ACBP4_ARATH Acyl-CoA-binding domain-containing protein 4 OS=Arabidopsis thaliana OX=3702 GN=ACBP4 PE=1 SV=1,,,,,,
OG_09743,0.5650857478495969,FUN_042009-T1,Peve_00031038,Pocillopora_meandrina_HIv1___RNAseq.g15212.t1,three_way,48.658166666666666,,,,,,,,,,,,,,,,,
OG_08693,0.5645629134571188,FUN_037937-T1,Peve_00015638,Pocillopora_meandrina_HIv1___RNAseq.g26202.t1,three_way,78.55583333333333,FUN_037937-T1,Q5M9B1,,,,,51.3,226.0,6.9e-63,242.3,sp|Q5M9B1|SPSB3_XENLA SPRY domain-containing SOCS box protein 3 OS=Xenopus laevis OX=8355 GN=spsb3 PE=2 SV=1,,,,,,
OG_08252,0.5620019830850765,FUN_036161-T1,Peve_00039217,Pocillopora_meandrina_HIv1___RNAseq.g27496.t1,three_way,49.679833333333335,FUN_036161-T1,Q9D6X6,,,,,31.2,346.0,1.5e-33,145.2,sp|Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musculus OX=10090 GN=Prss23 PE=2 SV=2,,,,,,
